Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Evnin Luke
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   330,044    

Indirect Shares

   35,767,143      
Direct Value   $449,921    

Indirect Value

   $119,087,079      
Total Shares   36,097,187      
Total Value   $119,537,001      


iPass Inc $0 Tcr2 Therapeutics Inc. $449,921 iPass Inc $0 Tcr2 Therapeutics Inc. $449,921
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -18.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Oscient Pharmaceuticals Corp OSCIQ Director 0 2006-01-05 2,272,935    Premium*  
            Idenix Pharmaceuticals Inc IDIX 10% Owner 2004-07-27 0 2004-07-27 4,797,991    Premium*  
            Rigel Pharmaceuticals Inc RIGL 10% Owner 2004-07-02 0 2004-07-02 1,833,597    Premium*  
            iPass Inc IPAS 10% Owner 2004-02-09 26,043 2004-02-09 262,533    Premium*  
            Hemosense Inc HEM 10% Owner 2005-07-01 0 2007-11-06 0    Premium*  
            American Cryostem Corporation CRYO 10% Owner 2005-07-13 0 2005-07-19 2,931,531    Premium*  
            Radius Health Inc. RDUS Former 10% stockholder 0 2016-09-27 3,887,502    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Director 2013-06-13 0 2013-06-13 824,255    Premium*  
            Syndax Pharmaceuticals Inc SNDX Director, 10% Owner 2016-03-08 0 2016-03-08 2,168,691    Premium*  
            Harpoon Therapeutics, Inc. HARP Former 10% Owner 2019-02-12 0 2021-04-15 3,220,844    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2020-06-23 3,003,772    Premium*  
            Oncorus, Inc. ONCR Director, 10% Owner 0 2020-10-06 2,492,843    Premium*  
            Turmeric Acquisition Corp. TMPM Chief Executive Officer 2020-10-20 0 2020-10-20 415,500    Premium*  
            Werewolf Therapeutics, Inc. HOWL Director, 10% Owner 0 2021-05-04 4,284,172    Premium*  
            Tcr2 Therapeutics Inc. TCRR 10% Owner 2023-05-22 304,001 2023-05-22 3,370,977    Premium*  
* Premium Members only  

Records found :    107         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
OSCIQ Oscient Pharmaceuticals C... Director   –       •       •   2004-02-07 3 IO $0.00 $0 I/I 0 7,597,351 -
IDIX Idenix Pharmaceuticals In... 10% Owner   –       –       •   2004-07-21 3 IO $0.00 $0 I/I 0 5,306,362 -
RDUS Radius Health Inc. 10% Owner   –       –       •   2008-06-15 3 IO $0.00 $0 I/I 0 5,000,000 -
PCRX Pacira Pharmaceuticals, I... Director   –       •       •   2011-02-02 3 IO $0.00 $0 I/I 0 92,980 -
ONCR Oncorus, Inc. Director   –       •       •   2020-10-01 3 IO $0.00 $0 I/I 0 115,823 -
HOWL Werewolf Therapeutics, In... Director   –       •       •   2021-04-29 3 IO $0.00 $0 I/I 0 461,408 -
HARP Harpoon Therapeutics, Inc... Former 10% Owner   –       –      –    2021-04-15 4 AS $20.49 $21,555 I/I (1,052) 3,220,844 0 %
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-01-26 4 AS $21.08 $28,732 I/I (1,363) 4,339,955 0 %
HARP Harpoon Therapeutics, Inc... Director   –       •       •   2019-02-12 4 D $14.00 $21,336 I/I (1,524) 4,274,425 0 -
HARP Harpoon Therapeutics, Inc... Former 10% Owner   –       –      –    2021-04-14 4 AS $20.06 $34,714 I/I (1,671) 3,221,896 0 %
HARP Harpoon Therapeutics, Inc... Former 10% Owner   –       –      –    2021-04-13 4 AS $19.35 $37,806 I/I (1,943) 3,223,567 0 %
OSCIQ Oscient Pharmaceuticals C... officerTitle   –       •      –    2005-12-19 4 AS $2.36 $5,428 I/I (2,300) 3,563,235 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-06-12 4 AS $30.00 $73,050 D/D (2,435) 20,311 0 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-04-12 4 AS $20.72 $52,460 I/I (2,496) 3,225,510 0 %
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-04-15 4 AS $30.00 $77,250 I/I (2,575) 1,277,904 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-04-12 4 S $29.30 $100,089 I/I (3,416) 1,314,255 0 -
OSCIQ Oscient Pharmaceuticals C... officerTitle   –       •      –    2006-01-04 4 AS $2.30 $10,810 I/I (4,700) 2,325,835 -
OSCIQ Oscient Pharmaceuticals C... officerTitle   –       •      –    2005-12-29 4 AS $2.30 $11,270 I/I (4,900) 2,362,835 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-04-24 4 AS $30.04 $189,342 I/I (6,303) 1,163,486 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-05-22 4 AS $30.00 $220,200 I/I (7,340) 1,176,372 0 -
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-07-02 4 S $14.88 $116,786 I/I (7,847) 1,833,597 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-02-09 4 AS $20.25 $190,350 I/I (9,400) 3,421,357 0 %
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-05-31 4 AS $30.00 $298,050 I/I (9,935) 906,327 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-04-12 4 AS $30.00 $300,000 I/I (10,000) 1,280,479 0 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2021-02-05 4 AS $20.01 $203,542 I/I (10,172) 3,502,885 0 %
  107  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us